Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px
Organisation › Details

Algenex S.L. (Alternative Gene Expression S.L.)

ALGENEX is a private biotechnology company developing disruptive technologies for the production of protein-based recombinant biologics. ALGENEX´ first two platforms, TopBac® and CrisBio®, have both been developed on the back of baculovirus-based expression systems and have demonstrated their ability to optimize protein production by increasing the yield and quality of the proteins as well as in succeeding to produce proteins that are difficult-to-express. The use of ALGENEX´ technologies significantly increases the speed and versatility of expression of a wide variety of protein families and thereby allowing the acceleration of the development times of protein-based pharmaceutical or diagnostic products. *


Period Start 2005-01-01 splitoff
  Predecessor Instituto Nacional de Investigación y Tecnologia Agraria (INIA)
Products Industry CrisBio® baculovirus-expression platform
  Industry 2 animal vaccine
Region Region Madrid
  Country Spain (España)
  Street Centro Empresarial
  City 28223 Pozuelo de Alarcón (Madrid)
  Tel +34-91-452-4941
    Address record changed: 2019-03-10
Basic data Employees n. a.
    * Document for �About Section�: Algenex S.L.. (3/5/19). "Press Release: Algenex Closes Funding Round and Strengthens Team with Key Senior Manager Appointments". Madrid.
Record changed: 2019-03-10


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Algenex S.L. (Alternative Gene Expression S.L.)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top